Shaanxi Micot Pharmaceutical Technology Co Ltd

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Vol. 1Y

—

Shs. 5Y

—

Rev. 5Y

Div Yld LY

—

Div Yld TTM

—

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Shaanxi Mycotech Pharmaceutical Technology Co., Ltd. operates as a platform-based biotechnology company dedicated to accelerating the global innovation and development of next-generation bi-multi-specific peptide drugs. Its products include MT1013, which is a dual-targeting receptor agonist polypeptide that simultaneously targets the CaSR and the OGP receptor. It is designed for the treatment of SHPT, CKD-MBD with Osteoporosis and SHPT not on Dialysis. The company was founded by Wang Bing on January 19, 2007 and is headquartered in Xi'an, China.

Key people

Bing Wang

Chairman of the Board, President, Founder

Weiping Yu

Senior Vice President, Chief Technology Officer

Guoqin Fu

Head - Quality Analysis and Preparation Team

Mali Jiang

Chief Director - Biopharmaceutical Research

Ruiling Wang

Clinical Medical Researcher

URL

https://www.micot.cn

IPO date

Employees

Domiciled in

Incorporated in

Valuation

No data to show